Loading
Straumann Holding AG Stock: price and insider trades · Switzerland
1 insider bought €315k of shares over the last 90 days, the latest filed 28 Aug 2026.
Straumann Holding AG: what insiders have been doing
Straumann Holding AG, founded in 1954, is a Healthcare & Pharma company based in Basel, Switzerland. Its directors and officers file their transactions with SIX SER. 4 insiders have disclosed 23 filings since 18 October 2025.
Open-market activity splits into 16 purchases totalling €2.7M and 7 sales totalling €62.7M; 4 insiders sit on the buying side and 3 insiders on the selling side. Taken together, the sales exceed the purchases by €60.0M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 4 senior executives. At €55.8M, the sale published on 25 March 2026 is the largest of the period (0.37% of market cap).
Across the 178 companies tracked on its exchange, the median is 9 filings; at 23 filings, this issuer sits above that mark. Looking back to 2023, when coverage begins, insiders filed 34 purchases and 64 sales.
In the case of 6 purchases, another manager of the company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. The last insider purchase was made public on 28 August 2026, 50 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. Until a filing is published, the market cannot know about the trade.
Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Cytosorbents Corp. These figures are compiled from regulatory filings published by SIX SER. They describe what insiders did and are not a recommendation.
Insider Decl.
98
Thresholds
n/a
Buy Volume
€5M
34 ops. · all time
Sell Volume
€145M
64 ops. · all time
Who traded when
BuySaleAnonymous (Executive member of the board of directors / member of senior management)11 buys8 sales
Anonymous (Non-executive member of the board of directors)7 buys11 sales
Anonymous (an executive member of the board of directors / member of senior management)6 buys1 sale
Anonymous (a non-executive member of the board of directors)2 buys
Since the insiders bought
- Anonymous (a non-executive member of the board of directors)-0.7%Entry CHF 93.90 · Close 15 Oct 2026 CHF 93.20
- Anonymous (an executive member of the board of directors / member of senior management)-0.7%Entry CHF 93.84 · Close 15 Oct 2026 CHF 93.20
- Anonymous (Executive member of the board of directors / member of senior management)+20.6%Entry CHF 84.74 · Close at T+90 CHF 102.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Straumann Holding AG Buy (bullish), based on 19 analysts. Average price target: CHF 113.11.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 8,608 of 24,148 companies
58.7
score / 100
Value38
Quality80
FCF yld1.9%
Earn yld2.4%
EV/EBITDA24.5x
ROE17%
Gross mgn69%
Net mgn14%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CHF 93.04
Analyst consensus
19 analystsBuy
CHF 86.00Target CHF 113.11(+22%)CHF 136.00
Income statement
RevenueCHF 2.6B
Gross profitCHF 1.8B69% margin
EBITDACHF 628.5M24% margin
Net incomeCHF 355.9M14.0% margin
Valuation
PER (trailing)40.8x
PER (forward)24.2x
P/Book6.5x
Beta1.36
Balance sheet & cash
Market capCHF 14.8B
Total debtCHF 418.9M
Free Cash FlowCHF 280.5M
Debt / Equity21%
Profitability & ownership
ROE17.0%
ROA11.0%
% insiders28.8%
% institutions42.5%
Last declaration on 28 August 2026
Declarations98 total
1,000 shares@ CHF 92.860.0006% mcap31.5% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q8S00010
Canonical exit: 26 Nov 2026 (T+90)
2,200 shares@ CHF 92.000.0013% mcap68.5% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q8R00061
Canonical exit: 25 Nov 2026 (T+90)
▼
Anonymous (an executive member of the board of directors / member of senior management)
1,100 shares@ CHF 106.400.0008% mcap11.7% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q6U00036
▼
Anonymous (Executive member of the board of directors / member of senior management)
1,100 shares@ CHF 106.400.0008% mcap1.5% of flowISIN CH1175448666SIX:T1Q6U00036
▲
Anonymous (an executive member of the board of directors / member of senior management)
1,050 shares@ CHF 94.140.0007% mcap10.0% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q6100010
Canonical exit: 30 Aug 2026 (T+90)
▲
Anonymous (an executive member of the board of directors / member of senior management)
1,607 shares@ CHF 64.560.0008% mcap10.5% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q57000D3
Canonical exit: 5 Aug 2026 (T+90)
▲
Anonymous (an executive member of the board of directors / member of senior management)
1,510 shares@ CHF 64.560.0007% mcap9.8% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q57000F8
Canonical exit: 5 Aug 2026 (T+90)
▲
Anonymous (an executive member of the board of directors / member of senior management)
1,742 shares@ CHF 64.560.0008% mcap11.3% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q57000C5
Canonical exit: 5 Aug 2026 (T+90)
▲
Anonymous (an executive member of the board of directors / member of senior management)
2,517 shares@ CHF 64.560.0012% mcap16.4% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q57000B7
Canonical exit: 5 Aug 2026 (T+90)
▲
Anonymous (an executive member of the board of directors / member of senior management)
4,646 shares@ CHF 64.560.0022% mcap30.3% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q57000G6
Canonical exit: 5 Aug 2026 (T+90)
▲
Anonymous (Executive member of the board of directors / member of senior management)
4,646 shares@ CHF 64.560.0022% mcap4.0% of flowISIN CH1175448666SIX:T1Q57000G6
Canonical exit: 5 Aug 2026 (T+90)
▲
Anonymous (Executive member of the board of directors / member of senior management)
1,607 shares@ CHF 64.560.0008% mcap1.4% of flowISIN CH1175448666SIX:T1Q57000D3
Canonical exit: 5 Aug 2026 (T+90)
▲
Anonymous (Executive member of the board of directors / member of senior management)
1,510 shares@ CHF 64.560.0007% mcap1.3% of flowISIN CH1175448666SIX:T1Q57000F8
Canonical exit: 5 Aug 2026 (T+90)
▲
Anonymous (Executive member of the board of directors / member of senior management)
1,742 shares@ CHF 64.560.0008% mcap1.5% of flowISIN CH1175448666SIX:T1Q57000C5
Canonical exit: 5 Aug 2026 (T+90)
▲
Anonymous (Executive member of the board of directors / member of senior management)
2,517 shares@ CHF 64.560.0012% mcap2.1% of flowISIN CH1175448666SIX:T1Q57000B7
Canonical exit: 5 Aug 2026 (T+90)
1,800 shares@ CHF 81.98160.0011% mcap0.1% of flowISIN CH1175448666SIX:T1Q3V000E1
Canonical exit: 29 Jun 2026 (T+90)
634,400 shares@ CHF 80.560.37% mcap39.6% of flowISIN CH1175448666SIX:T1Q3P00082
1,400 shares@ CHF 76.37990.0008% mcap0.1% of flowISIN CH1175448666SIX:T1Q3K00034
Canonical exit: 18 Jun 2026 (T+90)
3,800 shares@ CHF 77.700.0022% mcap0.2% of flowISIN CH1175448666SIX:T1Q3J00036
Canonical exit: 17 Jun 2026 (T+90)
31,250 shares@ CHF 80.37350.019% mcap2.0% of flowISIN CH1175448666SIX:T1Q3G000G5
▼
Anonymous (Executive member of the board of directors / member of senior management)
430 shares@ CHF 92.78060.5% of flowISIN CH1175448666SIX:T1PC800040
34,625 shares@ CHF 100.03052.6% of flowISIN CH1175448666SIX:T1PBP000A6
564 shares@ CHF 104.200.0% of flowISIN CH1175448666SIX:T1PBD00077
2,336 shares@ CHF 94.82450.2% of flowISIN CH1175448666SIX:T1P9500010
1,275 shares@ CHF 94.0050.1% of flowISIN CH1175448666SIX:T1P8F00059
Canonical exit: 13 Nov 2025 (T+90)
25 of 98 declarations
About Straumann Holding AG
Straumann Holding AG is a leading global player in dental implantology and orthodontic solutions. Listed on the SIX Swiss Exchange (SMI/SPI) in Switzerland, the company offers investors a defensive healthcare profile with growth supported by innovation, demographic aging, and rising oral-care demand. Headquartered in Basel, Switzerland, Straumann was founded in 1954 and has evolved into an international reference in tooth replacement and aesthetic dentistry. ([straumann.com](https://www.straumann.com/us/en/dental-professionals/about/the-straumann-group.html?utm_source=openai))
The group operates across several complementary business lines: implantology, prosthetics, biomaterials, digital solutions, and orthodontics. Its portfolio includes the Straumann, Neodent, Medentika, Anthogyr, and ClearCorrect brands, along with technology partnerships and digital workflow tools. This broad offering allows the company to cover a significant part of the treatment chain, from implants to CAD/CAM restorations, guided surgery, intra-oral scanning, and clear aligners. ([straumann.com](https://www.straumann.com/group/en/home/about/contact-us/contact-our-brands.html?utm_source=openai))
Read moreShow less
From a competitive standpoint, Straumann stands out through strong scientific credibility, a broad global distribution network, and close relationships with dental professionals, laboratories, and dental service organizations. The group says its products, solutions, and services are available in more than 100 countries, giving it a highly diversified geographic footprint. Its strategy is built around clinical education, product innovation, manufacturing quality, and the gradual integration of digital technologies into treatment workflows. ([straumann.com](https://www.straumann.com/us/en/dental-professionals/about/the-straumann-group.html?utm_source=openai))
Recent developments point to continued operational momentum. The 2024 and 2025 disclosures highlight solid commercial trends, market-share gains, strategic execution improvements, and further progress in digital offerings. Straumann also continued to streamline its portfolio, including the divestment of DrSmile, in order to focus resources on its core businesses with the strongest conviction. Full-year 2025 results, published in early 2026, indicated continued organic growth and strategic progress despite a more volatile macroeconomic and geopolitical backdrop. ([straumann.com](https://www.straumann.com/group/en/discover/annualreport/2024.html?utm_source=openai))
For francophone investors, Straumann combines exposure to a structurally attractive dental healthcare market with strong brand leadership and innovation potential, while remaining sensitive to foreign exchange movements, discretionary demand in certain segments, and commercial execution in key geographies.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
